Large-scale testing (Phase 3)Active Not RecruitingNCT02443077
What this trial is testing
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Who this might be right for
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell TypeRefractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI) 94